title: [Acute angle-closure glaucoma complicating an intravitreal injection of bevacizumab].
abstract: BACKGROUND
  The use of anti-VEGF by intravitreal injection is being generalized, and the indications are multiplying. Ocular hypertension after injection can be a classic complication.
  
  
  METHODS
  We report the case of an acute angle-closure glaucoma that occurred immediately after an intravitreal injection of 0.05 ml of bevacizumab. The patient was suffering from intravitreal hemorrhage complicating retinal central venous occlusion. The treatment consisted of intravenous acetazolamide and mannitol, associated with a local treatment.
  
  
  CONCLUSIONS
  Elevation of intraocular pressure is frequent a short time after an intravitreal injection. However, this complication is more often moderate and transient, and does not usually require an adapted treatment. The physiopathology remains unclear. To our knowledge the occurrence of acute angle-closure glaucoma following an intravitreal injection is exceptional.
authors.affiliation: Service d'ophtalmologie 2, centre hospitalier national d'ophtalmologie des XV-XX, Paris, France. oudysemoun@hotmail.com
authors.forename: O
authors.initials: O
authors.lastname: Semoun
authors.forename: E
authors.initials: E
authors.lastname: Blumen-Ohana
authors.forename: N
authors.initials: N
authors.lastname: de Preobrajensky
authors.forename: J-P
authors.initials: JP
authors.lastname: Nordmann
mesh_terms: D000208:Acute Disease; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D015812:Glaucoma, Angle-Closure / Q000139:chemically induced*; D006801:Humans; D007267:Injections; D014822:Vitreous Body
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab